netFormulary Isle of Wight NHS
Formulary  
 Search
 Formulary Chapter 13: Skin - Full Chapter
Chapter Links...
 Details...
13.08.01  Expand sub section  Sunscreen preparations
 note 

Prescribing on Sunscreens is permitted if in line with ACBS approved indications/ criteria.

If this criteria is not met than prescribing should be reviewed and stopped. Recommend self care and OTC purchases

ONLY sunscreens with SPF30 + with UVB and 4/5* UVA ratings should be used.

Remind patients that sunscreens are not a substitute for covering skin and avoiding sunlight.

ACBS criteria requires patients to apply sunscreen correctly - liberally and thickly every 2 hours approx.

Prescribable for photosensitive skin disorders including genetic disorders, vitiligo, following radio-therapy, photo-aggravated rosacea, recurrent herpes simplex labialis and photodermatoses, including drug induced photosensitivity.

 

Sunsense ® Ultra
View adult BNF View SPC online View childrens BNF
First Choice
Green

SPF 50

Available in different pack sizes - 50ml, 125ml and 500ml

If large quantities needed 500ml is most cost effective for all sunscreen options

 
Uvistat ®
View adult BNF View SPC online View childrens BNF
Formulary
Green

SPF 30 or 50

Cream x125ml and Lipscreen available to prescribe

 

 
   
Anthelios XL® (Cream)
View adult BNF View SPC online View childrens BNF
Formulary
Green

SPF 50+

Only available as 50ml

 
   
13.08.01  Expand sub section  Photodamage
Fluorouracil (Actikerall®)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Indicated for low or moderately thick hyperkeratotic actinic keratosis

0.5% solution, with salicylic acid

 
   
Cytotoxic Drug Fluorouracil (Efudix®)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Indicated for superficial malignant and pre-malignant skin lesions

5% cream (use for 2 weeks, 2 week break, then for a further 2 weeks) 

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Drugs that may be initiated, stabilised and maintained by primary, secondary or tertiary care Secondary and tertiary care prescribing may be continued by primary care. [this does not indicate first/second line choice]  

Green Hospital

Items used by the Hospital but would not normally be continued into primary care. Primary care prescribers can change to GREEN first or second.   

Green plus

Initiation of drugs by primary care following written advice from secondary/ tertiary care advice.  

Yellow

Drugs that may be continued in primary care following initiation and stabilisation in secondary/tertiary care  

Amber

Items requiring a shared care agreement. These items should be initiated and stabilised by secondary or tertiary care. The GP should only be asked to take over prescribing through a formal shared care agreement. Secondary care will be expected to continue prescribing until the agreement is made.  

Red

Hospital/ Trust ONLY. These are items the secondary and tertiary care are responsible for prescribing and will need to continue to prescribe for long term maintenance. These items will NOT be prescribed in primary care. But primary care should be informed the patient is receiving these items. This will include NHSE funded items requiring repatriation.  

GP - Black

Items covered by NHSE ‘Should not prescribe in primary care list’ – See CCG policy on Drugs of limited clinical value  

GP - Grey

Grey List: Items covered by NHSE ‘Should not prescribe in primary care list’ that are not to be routinely prescribed but may be suitable in a defined population – See CCG policy on Drugs of limited clinical value  

netFormulary